Alexander O. Schuth - Aug 14, 2023 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
COFO and Secretary
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Aug 14, 2023
Transactions value $
-$65,613
Form type
4
Date filed
8/16/2023, 06:19 PM
Previous filing
Aug 14, 2023
Next filing
Aug 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$65.6K -2.77K -0.53% $23.67 519K Aug 14, 2023 See footnote F1, F2, F3
holding DNLI Common Stock 126K Aug 14, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2022.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.58 to $23.80 per share. Upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
F4 Includes 113,531 RSUs.